Good afternoon, readers. I’d like to use today’s column to pose a question I’ve asked many of my own friends and colleagues: Would you be willing to get a COVID vaccine that’s less effective but perhaps more convenient to receive? One week ago, Johnson & Johnson unveiled results from a global trial finding that its […]
Fantastic day, Bull Sheeters. That can be Fortune fund reporter Rey Mashayekhi, filling in this week to get Bernhard using a distinctive PM version of this newsletter. Having only had a {} November, markets across the globe kicked off December in fashion, spurred by optimistic production data outside of Asia and great coronavirus vaccine information […]